Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes (Q42513731)

1 November 2017

Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes (English)

1 reference

ubiquitin-proteasome system

1 November 2017

0 references

1 reference

Jacqueline M Stephens

series ordinal

2

object named as

Jacqueline M Stephens

1 reference

1 November 2017

Z Elizabeth Floyd

1

1 reference

PubMed ID

11733495

1 November 2017

language of work or name

English

0 references

publication date

30 November 2001

1 reference

Journal of Biological Chemistry

1 November 2017

1 reference

1 November 2017

277

1 reference

1 November 2017

4062-4068

1 reference

1 November 2017

6

1 reference

Ligand-protein interactions in nuclear receptors of hormones.

1 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

PPAR gamma is required for placental, cardiac, and adipose tissue development

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Cytokines induce catabolic effects in cultured adipocytes by multiple mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

The effects of interferon on 3T3-L1 cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Activation of signal transducers and activators of transcription 1 and 3 by leukemia inhibitory factor, oncostatin-M, and interferon-gamma in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Effect of interferon on glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Hyperglycaemia due to insulin resistance caused by interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Themes and variations on ubiquitylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Importance of the regulation of nuclear receptor degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Proteasome-dependent degradation of the human estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Degradation of the basic helix-loop-helix/Per-ARNT-Sim homology domain dioxin receptor via the ubiquitin/proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Basic Medical Research Award. The ubiquitin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Proteasome inhibitors: valuable new tools for cell biologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

The nuclear ubiquitin-proteasome system degrades MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

mdm-2 gene amplification in 3T3-L1 preadipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Activation of protein kinase C triggers its ubiquitination and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Nuclear-specific degradation of Far1 is controlled by the localization of the F-box protein Cdc4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Ubiquitin-mediated proteolysis of a short-lived regulatory protein depends on its cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Peroxisome proliferator-activated receptor gamma and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M108473200

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

21 January 2018

1 reference

COCI

https://opencitations.net/index/coci/api/v1/citations/10.1038/47254

15 July 2023

Identifiers

DOI

10.1074/JBC.M108473200

1 reference

1 November 2017

1 reference

PubMed ID

11733495